UK Healthcare Services Group
- STRATEGY & BUSINESS ANALYSIS
- MARKET & SECTOR RESEARCH
- OPERATING COMPANY
The Client
A mid-market healthcare services group operating across multiple sites in the UK, backed by a regional private equity sponsor. The business had grown through a combination of organic expansion and bolt-on acquisitions over a three-year period, reaching a point where the leadership team needed to step back and evaluate its strategic positioning before committing to the next wave of investment.
The Challenge
The company had no dedicated strategy function. The CEO and CFO were making growth decisions based on operational intuition and sponsor input, but lacked a structured view of the competitive landscape, adjacent market opportunities, and the relative attractiveness of different expansion paths. The PE sponsor was pushing for a clear value creation plan ahead of a potential exit in 18–24 months, and the board needed a rigorous analytical foundation to support that planning. Internally, the team did not have the bandwidth or the research capability to produce this work. Hiring a strategy consultancy for a one-off engagement felt disproportionate, and the company wanted an ongoing analytical relationship rather than a single deliverable.
What Quantiva Delivered
Quantiva was engaged to take full ownership of the strategic analysis workstream. Our team conducted a comprehensive market mapping exercise across the UK healthcare services landscape, identifying competitive positioning, white-space opportunities, and potential acquisition targets across adjacent segments.
We built a detailed competitive benchmarking framework that allowed the leadership team to assess their performance relative to comparable operators across key metrics including site-level economics, workforce utilisation, and patient volume trends. This framework became a recurring analytical tool the board used in subsequent quarterly reviews.
In parallel, we produced a structured market entry analysis for two adjacent service verticals the company was considering. This included addressable market sizing, regulatory considerations, competitive density, and a financial scenario model projecting returns under different entry strategies.
All deliverables were produced to board-presentation standard and presented directly to the company’s executive team and PE sponsor.
The Outcome
The board approved entry into one of the two adjacent verticals based on Quantiva’s analysis, with the second deprioritised on the basis of competitive density and margin pressure identified in our research. The value creation plan was presented to the PE sponsor’s investment committee and formed the basis of the company’s pre-exit positioning strategy. Quantiva’s engagement continued beyond the initial project, with the team retained to provide ongoing competitive monitoring and ad hoc strategic analysis as the company executed against the plan.
